Using gene expression data to direct breast cancer therapy: evidence from a preclinical trial.
Using gene expression data to direct breast cancer therapy: evidence from a preclinical trial.
复制标题
DOI:
10.1007/s00109-017-1620-7
复制
发表时间:
2018-03
期刊:
影响因子:
--
通讯作者:
Andrechek ER
中科院分区:
文献类型:
--
作者:
Reaz S;Tamkus D;Andrechek ER
The heterogeneity both within and between breast cancers presents a significant clinical challenge for both diagnosis and therapy. This heterogeneity is present at all levels of analysis in breast cancer, ranging from genomic to metabolomic. A function of this heterogeneity is that numerous signaling networks are activated, and while treatment of one arm may be initially effective, this allows the tumor to be poised to evolve a resistance mechanism. Here we review the classification of breast cancers and discuss therapy of hormone positive, HER2 positive, and triple negative breast cancers. Model systems for breast cancer are examined allowing for a preclinical trial using a personalized medicine approach to be tested. This preclinical trial was based solely on cell signaling pathway activation and effectively and specifically blocked tumor growth in a preclinical model system.
登录
查看更多内容
影响因子:
8
作者:
通讯作者:
--
DOI:
10.1073/pnas.0912708107
发表时间:
2010-04-13
影响因子:
11.1
作者:
Gatza, Michael L.;Lucas, Joseph E.;Nevins, Joseph R.
通讯作者:
Nevins, Joseph R.
影响因子:
12.3
作者:
Herschkowitz JI;Simin K;Weigman VJ;Mikaelian I;Usary J;Hu Z;Rasmussen KE;Jones LP;Assefnia S;Chandrasekharan S;Backlund MG;Yin Y;Khramtsov AI;Bastein R;Quackenbush J;Glazer RI;Brown PH;Green JE;Kopelovich L;Furth PA;Palazzo JP;Olopade OI;Bernard PS;Churchill GA;Van Dyke T;Perou CM
通讯作者:
Perou CM
影响因子:
45.3
作者:
Adams, Sylvia;Gray, Robert J.;Badve, Sunil S.
通讯作者:
Badve, Sunil S.
影响因子:
11.2
作者:
Fujiwara, Kenichiro;Yuwanita, Inez;Andrechek, Eran R.
通讯作者:
Andrechek, Eran R.